Genetic Testing Advisory Committee

New genetic tests are being rapidly developed and promoted as high tech tools to improve diagnostic medicine and facilitate patient treatment. A formal evaluation process is required to assess the validity and effectiveness of new and existing genetic tests to better manage health care spending.

The Genetics Testing Advisory Committee was established in April 2014 with a three year mandate to review the clinical utility and validity of genetic tests and provide advice to the Ministry of Health and Long-Term Care on the provision of genetic tests in Ontario. The Creation of the Genetics Testing Advisory Committee was in keeping with the direction of the Excellent Care for All Act and the Ontario Action Plan for Health Care to promote the delivery of high-quality health care based on the best available scientific and clinical evidence.

The purpose of Genetics Testing Advisory Committee was to review and provide reports on existing and new genetic tests. These reports, in addition to other factors (e.g. implementation feasibility, available funding and resources, system level impacts, and social and ethical factors) will guide the Ministry’s decision-making on public funding of genetic tests in Ontario.

Members of the Genetics Testing Advisory Committee are from across Ontario and Canada. They have expertise and experience in:

• Genomics / personalized medicine
• Laboratory genetic testing
• Clinical genetics
• Genetic test utility / health technology assessment research
• Related clinical expertise
• Health economics
• Bioethics

Genetics Testing Advisory Committee mandate concluded on January 30, 2017.